These findings therefore reinforce the appropriateness of the Alb-R26Met cancer model as a relevant genetic system to study the epigenetic reprogramming associated with cancer, which we addressed by bioinformatically integrating data from methylome and transcriptome screens (Fig. 1a). Here, ALB is linked to cancer.